{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "11933090", "DateCompleted": {"Year": "2002", "Month": "06", "Day": "17"}, "DateRevised": {"Year": "2019", "Month": "09", "Day": "22"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0947-6539", "JournalIssue": {"Volume": "8", "Issue": "7", "PubDate": {"Year": "2002", "Month": "Apr", "Day": "02"}}, "Title": "Chemistry (Weinheim an der Bergstrasse, Germany)", "ISOAbbreviation": "Chemistry"}, "ArticleTitle": "The total synthesis of the annonaceous acetogenin, muricatetrocin C.", "Pagination": {"StartPage": "1621", "EndPage": "1636", "MedlinePgn": "1621-36"}, "Abstract": {"AbstractText": ["The total synthesis of the potential antitumour agent muricatetrocin C has provided an ideal stage for the exploitation and development of new chemistry. A convergent synthetic strategy has been realised incorporating three distinct pieces of methodology, these include a highly diastereoselective hetero-Diels-Alder reaction to construct the butenolide terminus, an oxygen to carbon rearrangement to install the trans-2,5-disubstituted tetrahydrofuran ring and a spatial desymmetrisation process to afford the anti-diol unit."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, University of Cambridge Lensfield Road, Cambridge, CB2 1EW, UK."}], "Identifier": [], "LastName": "Dixon", "ForeName": "Darren J", "Initials": "DJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ley", "ForeName": "Steven V", "Initials": "SV"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Reynolds", "ForeName": "Dominic J", "Initials": "DJ"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Chemistry", "NlmUniqueID": "9513783", "ISSNLinking": "0947-6539"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Furans"}, {"RegistryNumber": "0", "NameOfSubstance": "muricatetrocin C"}, {"RegistryNumber": "8KXK25H388", "NameOfSubstance": "butenolide"}, {"RegistryNumber": "OL659KIY4X", "NameOfSubstance": "4-Butyrolactone"}], "MeshHeadingList": [{"QualifierName": ["analogs & derivatives"], "DescriptorName": "4-Butyrolactone"}, {"QualifierName": ["chemical synthesis", "chemistry"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["chemical synthesis", "chemistry"], "DescriptorName": "Furans"}, {"QualifierName": [], "DescriptorName": "Molecular Conformation"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Stereoisomerism"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2002", "Month": "4", "Day": "5", "Hour": "10", "Minute": "0"}, {"Year": "2002", "Month": "6", "Day": "18", "Hour": "10", "Minute": "1"}, {"Year": "2002", "Month": "4", "Day": "5", "Hour": "10", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["11933090", "10.1002/1521-3765(20020402)8:7<1621::aid-chem1621>3.0.co;2-8", "10.1002/1521-3765(20020402)8:7<1621::AID-CHEM1621>3.0.CO;2-8"]}}], "PubmedBookArticle": []}